An inhibitor of Group IIA sPLA2
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LY311727

Item No. 17973

Technical Information
Formal Name
P-[3-[[3-(2-amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonic acid
CAS Number
164083-84-5
Molecular Formula
C22H27N2O5P
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/mlPBS (pH 7.2): 2 mg/ml
λmax
225, 283 nm
SMILES
OP(CCCOC1=CC=C(N(CC2=CC=CC=C2)C(CC)=C3CC(N)=O)C3=C1)(O)=O
InChi Code
InChI=1S/C22H27N2O5P/c1-2-20-19(14-22(23)25)18-13-17(29-11-6-12-30(26,27)28)9-10-21(18)24(20)15-16-7-4-3-5-8-16/h3-5,7-10,13H,2,6,11-12,14-15H2,1H3,(H2,23,25)(H2,26,27,28)
InChi Key
OPWQYOUZRHDKBR-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products
Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    LY311727 is an inhibitor of Group IIA sPLA2 (IC50 = 0.47 µM) that interacts with the active site of the enzyme in a non-covalent manner.1,2 It shows greater than 1,500-fold selectivity over pancreatic sPLA2 (Group IB sPLA2).2 LY311727 is commonly used to distinguish the actions of Group IIA sPLA2 from those of other sPLA2 isoforms in biological systems.3,4,5,6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Dong, C.Z., Romieu, A., Heymans, F., et alTotal direct chemical synthesis and biological activities of human group IIA secretory phospholipase A2. Biochem. J. 365, 505-511 (2002).

    2. Schevitz, R.W., Bach, N.J., Carlson, D.G., et alStructure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nat. Struct. Biol. 2(6), 458-465 (1995).

    3. Hurt-Camejo, E., Andersen, S., Standal, R., et alLocalization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17, 300-309 (1997).

    4. Thommesen, L., Sjursen, W., Gåsvik, K., et alSelective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-κB and expression of ICAM-1. J. Immunol. 161, 3421-3430 (1998).

    5. Shinohara, H., Balboa, M.A., Johnson, C.A., et alRegulation of delayed prostaglandin production in activated P388D1 macrophages by group IV cytosolic and group V secretory phospholipase A2s. The Journal of Biological Chemisty 274(18), 12263-12268 (1999).

    6. Balsinde, J., Shinohara, H., Lefkowitz, L.J., et alGroup V phospholipase A2-dependent inducation of cyclooxygenase-2 in macrophages. The Journal of Biological Chemisty 274, 25967-25970 (1999).